2010
R.M. Lloyd Jr, R. Diaz, C. Loveday, K. T. Presley, RL Mathis, PM Feorino, Z. Grossman and M. Holodniy. COMPARISON OF HEPATITIS QUANTITATIVE AND QUALITATIVE METHODS USING VIVEST SAMPLE TRANSPORTATION MATRIX VS FROZEN PLASMA. Presented at 26th Annual Clinical Virology Symposium April 25 – 28, 2010 Daytona Beach, Florida USA
R.M. Lloyd Jr, R. Diaz, C. Loveday, K. T. Presley, RL Mathis, and M. Holodniy. VERSANT HIV RNA 3.0 and M2000 REAL TIME HIV-1 VIRAL LOAD TESTING AFTER USING ViveST™ SAMPLE TRANSPORTATION MATRIX. Presented at 26th Annual Clinical Virology Symposium April 25 – 28, 2010 Daytona Beach, Florida USA
M. Holodniy1, R.S. Diaz2, R.L. Mathis3, P.M. Feorino3, C. Loveday4, Z. Grossman5, R. Kantor6, Y.W. Tang7, R.M. Lloyd, Jr . DETECTION OF MIXTURES OF HEPATITIS C VIRUS (HCV) TYPES Presented at the 45h Annual International Liver Conference. April 14 – 18, 2010 Vienna, Austria.
M. Holodniy*, R.S. Diaz, R.L. Mathis, P.M. Feorino, C. Loveday, Z. Grossman, R. Kantor, Y.W. Tang, R.M. Lloyd Jr. Detection and characterization of mixtures of hepatitis C virus (HCV) types. Presented at the European Congress of Clinical Microbiology and Infectious Disease. April 10 – 13, 2010 Vienna, Austria.
R.M. Lloyd Jr,, M Holodniy, D Burns, RS Diaz, C Loveday, LMR Janini, Z Grossman . A Co-linear Assay for Detection of HIV-1 Drug Resistance to Approved and Investigational Drugs. Presented at the International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies June 8-12, 2010 Dubrovnik, Croatia.
C Loveday1, RM Lloyd Jr3,.E MaCrae1, Z Grossman4 , R Mathis3, D Burns3, R. Diaz & M. Holodniy. Comparison of ViveST™, a Novel Dried Plasma Transportation Matrix, to Frozen Plasma Using a Quantitative HIV-1 Viral Load Assay. Presented at the American Association for Clinical Chemistry, July 27-31, 2010, Anaheim, CA USA.
Robert M. Lloyd Jr, Clive Loveday, Ricardo Diaz , Darrell A. Burns, Rodney L. Mathis, Rami Kantor, Zehava Grossman & Mark Holodniy. Evaluation of ViveST™ vs Frozen Plasma for HIV-1 Viral Load Testing in Brazil
Using a Quantitative HIV-1 Viral Load Assays. Presented at the American Association for Clinical Chemistry, July 27-31, 2010, Anaheim, CA USA.
2009
Clive Loveday1, Zehava Grossman2, Robert M. Lloyd, Jr.3, Darrell A. Burns3, Rodney L. Mathis3, Judy L. Cooper3, Georgianna Simmons3, and Mark Holodniy. Cost Effectiveness of International Shipment of Dried Plasma for HIV Resistance Testing. Presented at the Conference on HIV Pathogenesis, Treatment and Prevention July 19-21, 2009. Cape Town, South Africa.
C. Loveday1, E. MaCrae1, M. Holodniy2, R. Mathis3, D. Burns3, J. Cooper3 Z. Grossman4 & R.M. Lloyd Jr3. Evaluation of SampleTanker® for Collection, Storage and Transport of Dried Plasma from a Resource-Limited Setting (R-LS) to a Resource-Rich Setting (R-RS) for HIV-1 Genotypic Analysis. Presented at the XVIII International HIV Drug Resistance Workshop June 9-13, 2009 Ft. Myers, Florida, USA.
Rami Kantor*, 2Lameck Diero, 1Allison DeLong, 3Maya Balamane, 4Robert Lloyd, 2Wilfred Injera, 2Lydia Kamle, 2Fidelis Mambo, 2Sarah Muyonga, 2Lucy Watetu, 1Jane Carter, 3David Katzenstein, 1Joe Hogan, 2Nathan Buziba, HIV Diversity and Drug Resistance in Western Kenya From Plasma and non-Plasma Genotyping. XVIII International HIV Drug Resistance Workshop June 9-13, 2009 Ft. Myers, Florida, USA.
2008
R.M.Lloyd Jr., R.L. Mathis, P.M. Feorino and W.A. O’Brien. Detection of Mixtures of Hepatitis C Virus (HCV) Genotyping. Presented at the 17th International HIV & Hepatitis Drug Resistance Workshop June 10-14, 2008 Melia Sitges, Spain.
S. Erickson-Viitanen, K. Abremski, K. Solomon, R. Levy, E. Lam, J. Whitcomb, R. Lloyd, Jr., R. Mathis, J. Reeves and D. Burns.
Co-Receptor Tropism, ENV Genotype, and in vitro Susceptibility to CCR5 Antagonists During a 14-Day Monotherapy Study with INCB9471. Presented at the Conference for Retrovirus and Opportunistic Infection February 3-6, 2008 Boston, MA USA
RM Lloyd, Jr, M Holodniy, RL Mathis, WA O’Brien, DA Burns, JL Cooper, KT Presley and PM Feorino. Stability of HIV-1 Viral Load From Dried Plasma Using SampleTanker®, A Novel Dried Plasma Transportation Matrix. Presented at 24th Annual Clinical Virology Symposium April 25 – 29, 2008 Daytona Beach, Florida USA
2006
Susan Erickson-Viitanen, K Hou, R Lloyd Jr, R Mathis, D Burns, R Goyvaerts, and R Levy. Baseline Genotype/Phenotype, Virological Response, and Lack of de novo Resistance Mutation Generation during Therapy with Dexelvucitabine (Formerly Reverset) in Study RVT-203. Presented at the 13th Conference on Retroviruses and Opportunistic Infection, Denver, CO USA. February 5-8, 2006.
RM Lloyd Jr, DA Burns, JT Huong, RL Mathis, M Holodniy, K Gilonske and PM Feorino. Abilities of Different HCV Genotyping Assays to Detect Minor Populations: Implications for Drug Therapy? Presented at the 22nd Clinical Virology Symposium. Clearwater Beach, FL. April 30 – May 03, 2006.
R. Lloyd, J. Huong, E. Rouse, P. Gerondelis, M. Lim, M. Shaefer, A. Rodriguez, J. Gallant, R. Lanier, L.L. Ross. HIV-1 RT Mutations K70E and K65R Are Not Present on the Same Viral Genome When Both Mutations Are Detected in Plasma. Presented at the 46th ICAAC September 27-30, 2006 San Francisco, CA USA
2005
R. Lloyd, Jr., J Huong J., E. Rouse, P. Gerondelis, M. Lim , M. Shaeffer, A. Rodriguez, J. Gallant, R. Lanier, and L. L. Ross. HIV-1 RT Mutations K70E and K65R are not Present on the Same Viral Genome when Both Mutations are Detected in Plasma. Presented at the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy Washington D.C. USA December 16-19, 2005.
RM Lloyd JR, DA Burns, JT Huong, BD Kirkpatrick RL Mathis, M Holodniy, ML Tanner, and PM Feorino COMPARISON OF WHOLE BLOOD, PLASMA, AND PBMC HIV-1 RESISTANCE GENOTYPING AND MATCHED DRIED SAMPLES USING SampleTanker™ A NOVEL DRIED TRANSPORTATION MATRIX. Presented at the XIV International HIV Drug Resistance Workshop Quebec City, Quebec Canada. June 7-11, 2005
JT Huong, DA Burns, BD Kirkpatrick, RT Prince, M Holodniy, and RM Lloyd JR RESISTANCE GENOTYPING USING A NOVEL LONG RANGE AMPLICON SYSTEM, HIV-1 LR-GeneTanker™ COMPLETE. Presented at the XIV International HIV Drug Resistance Workshop Quebec City, Quebec Canada. June 7-11, 2005
J. Huong, D. Burns, B. Yen-Liebermann, D. McClernon, B. Kirkpatrick and R. Lloyd, Jr. EVALUATION OF MINIMAG EXTRACTION AS A RAPID METHOD OF ISOLATING HEPATITIS B VIRAL NUCLEIC ACID FOR ANALYSIS USING THE INNO-LiPA LINE-PROBE ASSAY. Presented at the 21st Clinical Virology Symposium Clearwater Beach, FL USA. May 8-11, 2005
R. Lloyd, JR, J. Huong, D. Burns, B. Yen-Liebermann, C. Starkey, B. Kirkpatrick and M. Holodniy. COMPARISON OF HEPATITIS B VIRUS INNO-LiPA GENOTYPING BETWEEN FROZEN PLASMA AND SampleTanker™ A DRIED TRANSPORTATION MATRIX. Presented at the 21st Clinical Virology Symposium Clearwater Beach, FL USA. May 8-11, 2005
J. Huong, D. Burns, R. Mathis, B. Kirkpatrick and R. Lloyd, JR. GENOTYPING OF HIV-1 PROVIRAL DNA FROM PBMC’s USING TRUGENE™ HIV-1 GENOTYPING ASSAY AND NucliSens® Mini Mag EXTRACTION. Presented at the Clinical Virology Symposium Clearwater, FL USA. May 8-11, 2005
J. Huong, D. Burns, R. Mathis, B. Kirkpatrick, M. Tanner and R. Lloyd, JR. PILOT VALIDATION OF THE TRUGENE™ HIV-1 GENOTYPING ASSAY ON LOW LEVEL VIREMIA SAMPLES. Presented at the Clinical Virology Symposium Clearwater, FL USA. May 8-11, 2005
R. Lloyd, JR, J. Huong, D. Burns, R. Mathis, B. Kirkpatrick and M. Holodniy. PILOT VALIDATION OF TRUGENE™ HIV-1 GENOTYPING FROM WHOLE BLOOD EXTRACTIONS Presented at the Clinical Virology Symposium Clearwater, FL USA. May 8-11, 2005
RM Lloyd JR, M Holodniy, DA Burns, JT Huong, DR McClernon, I Levy, M Lorber, S Pollack, K Riesenberg and Z Grossman. Successful International Ambient Patient Plasma Transport of HIV-1 Clade A, B and C Using SampleTankerTM, a Novel Dried Transportation Matrix. Presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA USA. February 22-25, 2005
2004
R.M. Lloyd JR, D.A. Burns, A. Thompson, J.T. Huong, R.L. Mathis, M. Holodniy, B. Yen-Lieberman, W. Armstrong, A. Taege and P.M. Feorino. Comparison of Viral Load and Resistance Genotyping Between Frozen Plasma and a Novel Dried Plasma Transportation Medium (SampleTankerTM) on Treated Patient Samples. Presented at the XIII International HIV Drug Resistance Workshop Tenerife Sur-Costa Adeje, Canary Islands, Spain. June 8-12, 2004
Lloyd R.M. JR, Johnson R., Thompson A., Huong J., Burns D., Yen-Lieberman B., Armstrong W., Taege A., and Feorino P. BASELINE GP41 SEQUENCES IN T-20 (ENFUVIRTIDE) NAIVE PLASMA SPECIMENS. Presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy Washington D.C. October 30 – November 2, 2004
J. Huong, G. Talekar, A. Thompson, M. Rosser, P. Feorino, H. Fields and R. Lloyd, Jr. EVALUATION OF THE HCV GENETANKER NS5B ASSAY AS A NOVEL METHOD FOR SUBTYPING AND RESISTANCE GENOTYPING OF HEPATITIS C VIRUS. Presented at the 20th Clinical Virology Symposium, Clearwater Beach, FL April 25-28, 2004
R. Johnson JR, J. Huong, P. Berger, R. Mathis, B. Yen-Liebermann, W. Armstrong, A. Taege, Calabrese L, and R.M. Lloyd JR. SEQUENTIAL RESISTANCE GENOTYPING OF A SALVAGE PATIENT RECEIVING T20 (enfuviritide) USING A NOVEL NUCLEOTIDE SEQUENCING ASSAY. Presented at the 20th Clinical Virology Symposium, Clearwater Beach, FL April 25-28, 2004
2001
R. M. Grant, R. M. Lloyd, R.D. Aquila, J.L. Sullivan, R. Swanstrom, V. Johnson, J. Mellors, M. Holodniy., C. Reid, G. Morgan, D. L. Winslow, Reproducibility and Accuracy of a Novel Kit-Based Genotyping Assay for HIV-1 Drug Resistance. 8th Conference on Retroviruses and Opportunistic Infections., February 4-8, 2001 Sheraton Chicago Hotel and Towers, Chicago, IL.
M. Parker, N. Wade, B.K. Gallagher, B. Cheku, R.M. Lloyd Jr., T. Sullivan, G. Birkhead, and J. Taylor. New York State Dept. of Health, Albany , NY and Applied Sciences, Inc., Suwanee, GA. Prevalence of Genotypic Drug Resistance in HIV-Infected Newborns in New York State (NYS). 8th Conference on Retroviruses and Opportunistic Infections., February 4-8, 2001 Sheraton Chicago Hotel and Towers, Chicago, IL.
Jagodzinski, L., Cooley, J., Stang, H., Dolinger, D., Lloyd, R., Differences in Performance Between the TRUGENE HIV-1 Genotyping Kit and the ViroSeq HIV-1 Genotyping System.,17th Annual Clinical Virology Symposium, Clearwater, Florida, April, 2001.
J. Huong, C. Sturchio, A.De La Rosa, R.Lloyd Jr., and M. Healy. A Rapid Sequencing Method Using the TRUGENE HBV Genotyping Kits for Hepatitis B Virus Genotyping and Detection of Drug Resistance Mutation. 17th Annual Clinical Virology Symposium. Clearwater Beach Fl., April 29 – May 2, 2001.
R.M. Lloyd Jr., M Tanner, H.Stang, J Huong, C Rold, R Mathis, D Burns, L Hough, and D Dolinger. Sequential Genotyping of Treated Patients in Plasma, Blood Provirus, Seminal Plasma, and Seminal Provirus Compartments. 2001. 5th International Workshop on HIV Drug Resistance and Treatment Strategies,
P. Fiette, E. Gault, A. Monnet, R. Lloyd, C. Naudin. Use of a novel set of RT-PCR primers in conjunction with TRUGENE HIV-1 Genotyping Kit provides reliable genotypes of difficult patient specimens. 8th Conference on Retroviruses and Opportunistic Infections., February 4-8, 2001 Sheraton Chicago Hotel and Towers, Chicago, IL.
R. Kantor, R. Lloyd, R. Shaer, E. Johnston, L. Guay, J. Jackson, S. Eshlemen, D. Katzenstein for the HIVNET 012 and 023 teams. Comparison of mother to child transmission (MTCT) and genotypic resistance in HIV-1 Subtypes A, C and D after single dose nevirapine (sd-NVP) in Africa. . 8th Conference on Retroviruses and Opportunistic Infections., February 4-8, 2001 Sheraton Chicago Hotel and Towers, Chicago, IL.
2000
O’Brien, W.A., Telleria, L., Borucki, M., Han, X., Attkinson, T.L., Pollard, R.B., Lloyd, R.M., Jr.;(2000) HIV Drug Resistance in the Texas Department of Corrections. 40th ICAAC, Toronto, Ontario, Canada, September 16-20, 2000.
Lloyd, R.M., Jr., Dolinger, D.L., McClernon, D.R., Stang, H.L., Hough, L.M., Burns, D.A., Mathis, R.L., Huong, J.T., Wagar, N.A., Feorino, P.M.;(2000) Polymorphic Fingerprint as a Positive Control in HIV-1 Resistance Genotyping from Low-Level Sequential Patient Isolates in a Therapy Naïve Study. 40th ICAAC, Toronto, Ontario, Canada, September 16-20, 2000.
Day, S., Hough, L.M., Huong, J.T., Mathis, R.L., Dolonger, D.L., Lloyd, R.M., Jr.; (2000) Reproducibility of Results Generated by a Kit-Based HIV-1 Genotypic Assay Demonstrated when Compared to Laboratory Developed “Home Brew” Genotypic and Phenotypic Assays Offered Through Reference Laboratories. US Conference on AIDS, October 1-4, 2000, Atlanta, Georgia
J. Huong, D.L. Dolinger, M. Healy, A. De La Rosa, and R.M. Lloyd Jr. Validation of the TRUGENE HBV Genotyping Assay Algorithm. Chronic Viral Hepatitis Symposium. Philadelphia Pennsylvania. Nov. 9 – 10, 2000.
1999
D. Rushlow, S. Amato, Lloyd, R.M, Jr., Marcheletta, K., LaCroix, J.M (1999) Patient Sample Testing Using Hepatitis B Virus (HBV) Genotyping Assay from Visible Genetics. Tenth International Symposium on Viral Hepatitis and Liver Disease, Atlanta, Georgia, April 9-13, 1999.
Harris, J.L.., Lu, F., Bae, A., Borroto-Esota, K., Stang, H.L., Huong, J.T., Lloyd, R.M., Jr., McCreedy, B.; (1999) Incorrect Determination oh HIV-1 Genotypic Drug Resistance by Hybridization-Based Sequencing Methods. 3rd International Workshop on HIV Drug Resistance and Treatment Strategies, San Diego, California, June 23-26, 1999.
Harris, J.L.., Lu, F., Bae, A., Borroto-Esota, K., Stang, H.L., Huong, J.T., Lloyd, R.M., Jr., McCreedy, B.; (1999) Incorrect Determination oh HIV-1 Genotypic Drug Resistance by Hybridization-Based Sequencing Methods. 39th ICAAC, San Francisco, California, June 25-30, 1999.
Lawrence, J., Lloyd, R.M., Jr., McCarthy, W.F., Hough, L.M., Feorino, P.M., Thompson, M.A.; (1999) Genotypic Resistance Testing in Patients with Low-Level Viremia (<400 Copies/ml) Using a New Automated DNA Sequencing System. Infectious Disease Society of America, November 18-21, 1999.
LaCroix, J.M., Lloyd, R.M.,Jr., Hough, L.M., Feorino, P.M.(1998) Protease and Reverse Transcriptase Genotyping with Visible Genetics TruGene HIV Genotyping GeneKit. 12th World AIDS Conference, Geneva, Switzerland. June 28-July 3, 1998.
LaCroix, J.M, Lloyd, R.M., Jr., Batra, R., Bouevitch, A., Rushlow, , D., Dunn, J. (1998) Sequencing of the Protease and Reverse Transcriptase from HIV-1 Subtype A and D Using the Visible Genetics HIV-1 Genotyping . 38th ICAAC, SanDiego, Ca., September 24-27, 1998.
Lloyd, R.M., Jr., Stang, H.L., Huong, J.T., Mathis, R.L., Hough, L.M., Halfon, P, LaCroix, J.M., Manegold, C., Cyada, C., Carroll, R.J., Durant, G., Feorino, P.M.; (1998) HIV-1 Insertion Codon Mutants Identified in Patient Samples from Europe and USA by TruGene HIV-1 Assay. Fourth International Congress on Drug Therapy in HIV, Glasgow, Scottland, November 8-12, 1998.
Rimland D., Schinazi R.F., Lloyd Jr. R.M., Hough L., Ivester K., and Stuyver L.; (1997). Analysis of Baseline HIV-1 Genotypic Resistance and Association with Mortality in Patients with HIV Disease. 4th Conference on Retroviruses and Opportunistic Infections., Washington D.C. 21-27, 1997.
Schinazi R.F., McMillan A., Lloyd Jr. R.M., Schlueter-Wirtz S., Liotta D.C., and Chu C.K.; (1997). Molecular Properties of HIV-1 Resistant to (+)-Enantiomers and Racemates of Oxathiolane Cytosine Nucleosides and their Potential for the Treatment of HIV and HBV Infections. Tenth International Conference on Antiviral Research . Atlanta, GA. April 6-11, 1997.
Schinazi, R.F., Hough, L.M., Yao, X., Lloyd, R.M. Jr., Fallon, M., Sommadossi, J.-P., Fried, M.W., and Mead, J.R.; (1997) Hepatitis C Virus Infection in SCID Mice Using Xenografted Human Livers. Tenth International Conference on Antiviral Research . Atlanta, GA. April 6-11, 1997.
Stuyver, L., Schinazi, R.F., Wyseur, A., Lloyd, R.M., Jr., Scarcez, T., Rossau, R., and Rimland, D. (1995). Differences in HIV Provirus and Plasma Virus Reverse Transcriptase (RT) Gene Using a Line Probe Assay (LiPA). The Third Conference on Retrovirus and Opportunistic Infections, Washington, D.C., January 28- February 1, 1996.
Faraj, A., El Alaoui, M.A., Pavia, G., Gosselin, G., Lloyd, R.M., Jr., Juodawlkis, A.S., Schinazi, R.F., Aubertin, A.M., Imbach, J.-L., and Sommadossi, J.-P. (1996). ß-L-AZTMP- methyl-S-acyl-thioethyl (SATE), a prodrug of ß-L-AZT-5′-monophosphate with antiviral activities. The Third Conference on Retrovirus and Opportunistic Infections, Washington, D.C., January 28- February 1, 1996.
Smith R., Remington K., Lloyd R., Schinazi R., North T., (1996) Mutants of Feline Immunodeficiency Virus Resistant to FTC and 3TC. Third International Feline Retrovirus Research Symposium., March 6-9, 1996.
Schinazi, R.F., Stuyver, L., Wyseur, A., Lloyd, R.M., Jr., Hough L., Rombout R., Rossau, R., and Rimland, D. (1996). Proviral and Plasma Virus Genotyping Using A Line Probe Assay In Nucleotide Treated HIV Infected
Veterans Affairs (VA) Patients. Fifth International Workshop, Whistler, Canada., July 3-6, 1996.
Schinazi, R. F., Boudinot F. D., Manouilov K. K., Mellors J. W., McMillan A.,Schlueter-Wirtz S., Lloyd Jr. R. M., Korba B. E., Tennant B., Chu C. K., (1996). Anti-HBV and Anti-HIV Activities of Dioxolane-Purine Nucleosides. Ninth International Conference on Antiviral Research., Urabandai, Fukushima, Japan., May 19-24, 1996.
Bonafonte-Cimiano M-T.; Lloyd Jr. R. M.; Garmon D.; You X.; Arrowood M.; Schinazi R.F.; Mead J.; (1996). Caracterizacion De Proteinas Recombinantes De Criptosporidium Parvum. XIII Congreso LATINOAMERICANO De Microbiologia, Caracas., November 5-9, 1996.
Lesnikowski, Z.J., Fulcrand-El Kattan, G., Lloyd, R.M., Jr., and Schinazi, R.F. (1995) Biological Properties of Dodeca(thymidine phosphates) Containing 5-(o-Carboranyl-1-yl)-2′-deoxyuridine. Conference on Phosphorus Chemistry, Jerusalem, Israel, July 16-21 1995.
Lesnikowski, Z.J., Juodawlkis, A.S., Lloyd, R.M., Jr., Chu, C.K., and Schinazi, R.F. (1995) Synthesis and HIV-1 Reverse Transcriptase Inhibition of Penciclovir and ß-D-Dioxolane-Guanine Triphosphate. Conference on Phosphorus Chemistry, Jerusalem, Israel, July 16-21 1995.
Schinazi R. F., Juodawlkis A. S., Lloyd Jr. R. M., Lesnikowski Z. J., (1995) Differential Inhibition of Viral Polymerases by Enantiomers of Penciclovir Triphosphate. 35th ICAAC, San Fransisco, CA. April 3, 1995.
Schinazi, R. F.,Lloyd, R. M., Jr.,McMillan, A.,Gosselin, G.,Imbach, J.-L., & Sommadossi, J.-P. (1995). Development of HIV-1 and SIV resistant to ß-L-2′,3′-dideoxycytidine analogues. Fourth International Workshop on HIV Drug Resistance Sardinia, July 6-9, 1995.
Schinazi, R. F.,Lloyd, R. M., Jr.,McMillan, A.,Gosselin, G.,Imbach, J.-L.,Chu, C. K., & Sommadossi, J.-P. (1995). Antiviral resistance to enantiomers of 2′,3′-dideoxycytidine analogues – common threads. International Society for Antiviral Research, 8th International Conference on Antiviral Research., Santa Fe, NM, April 23-28, 1995.
Lesnikowski, Z. J.,Juodawlkis, A. S.,Lloyd, R. M., Jr., & Schinazi, R. F. (1995). Stereoselective synthesis of (S)- and (R)-penciclovir triphosphate and their activity against viral enzymes. International Society for Antiviral Research, Santa Fe, NM, April 23-28, 1995.
Taylor, E. W.,Ramanathan, C. S.,Lloyd, R. M., Jr., & Schinazi, R. F. (1994). Antiviral drug resistance mutations in HIV-1 reverse transcriptase occur in specific RNA structural regions. International Society for Antiviral Research, Charleston, SC, February 27-March 4, 1994.
Mead, J. R.,Lloyd, R. M., Jr. ,You, X. D.,Tucker-Burden, C.,Arrowood, M. J., & Schinazi, R. F. (1994). Identification of molecular targets for drug therapy against cytptosporidiosis. Advances in Biotechnology, Atlanta, GA, May 6-7, 1994.
Lloyd, R. M., Jr.,Huong, J. T.,McMillan, A., & Schinazi, R. F. (1994). A rapid and high capacity in vitro antiviral assay for hepatitis B virus using quantitative polymerase chain reaction (PCR). International Society for Antiviral Research, Charleston, SC, Feburary 27-March 4, 1994.
Mead, J. R.,Lloyd, R. M., Jr. ,You, X.,Tucker-Burden, C.,Arrowood, M. J., & Schinazi, R. F. (1994). Isolation and partial characterization of cryptosporidium sporozoite and oocyst wall recombinant proteins. 47th Annual Meeting of the Society of Protozoologists, Cleveland, OH, June 24-29, 1994.
Schinazi, R. F.,Lloyd, R. M., Jr.,McMillan, A.,Mathez, D. P.,Leibowitch, J., & Mellors, J. (1993). Molecular properties of HIV-1 resistant to 3TC and FTC. First National Conference on Human Retroviruses and Related Infections, Washington, DC, Dec. 12-16, 1993.
Schinazi, R. F.,Mathez, D. P.,Lloyd, R. M., Jr.,McMillan, A., & Leibowitch, J. (1993). Resistance and susceptibility of HIV to the antiviral agents AZT and 3TC: Quantitation and evolution in treated patients. Third Workshop on Viral Resistance, Gaithersburg, MD, Sept. 19-22, 1993.
Schinazi, R. F.,Lloyd, R. M., Jr.,McMillan, A.,Mathez, D. P.,Leibowitch, J., & Mellors, J. (1993). Molecular properties of HIV-1 resistant to 3TC and FTC. First National Conference on Human Retroviruses and Related Infections, Washington, DC, Dec. 12-16, 1993.
Mellors, J. W.,Lloyd, R. M.,Nguyen, M. H.,Chu, C. K.,Liotta, D. C., & Schinazi, R. F. (1993). Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. IXth International Conference on AIDS, Berlin, Germany, June 7-11, 1993.
Schinazi, R. F.,Lloyd, R.,Oswald, B., & Manning, C. (1991). Effect of AZT, AzddU, FDT, and BCH-189 nucleotides on DNA chain termination mediated by HIV-1 reverse transcriptase. International Society for Antiviral Research. Fourth International Conference on Antiviral Research, New Orleans, LA, April 21-26, 1991. Antiviral Res. 15 (S1):97.
Schinazi, R. F.,Lloyd, R.,Oswald, B., & Manning, C. (1991). Effect of AZT, AzddU, FDT, and BCH-189 nucleotides on DNA chain termination mediated by HIV-1 reverse transcriptase. Antiviral Res, 15(Abstract #98), 97